ACT-132577,
Aprocitentan,
ACT-132577,
1103522-45-7,
UNII-MZI81HV01P,
Despropyl Macitentan,
MZI81HV01P,
CHEMBL2165326,
CHEBI:76609,
5-(4-bromophenyl)-4-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-6-(sulfamoylamino)pyrimidine,
Macitentan metabolite,
ACT 132577,
Aprocitentan [USAN],
SCHEMBL3646065,
GTPL10070,
BCP28125,
BDBM50395672,
WHO 10552,
ZINC95553608,
CS-2687,
NCGC00378592-01,
BC600808,
HY-15895,
ACT132577;ACT 132577,
A-350,
5-(4-bromophenyl)-4-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-6-(sulfamoylamino)pyrimidine.,
N-[5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]sulfuric diamide,
N-Despropyl Macitentan,
CS-T-16586,